Opendata, web and dolomites

SkinFactory 2.0 SIGNED

SkinFactory 2.0: GMP-in-a-box

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SkinFactory 2.0 project word cloud

Explore the words cloud of the SkinFactory 2.0 project. It provides you a very rough idea of what is the project "SkinFactory 2.0" about.

medicine    prototype    treatment    skills    industrial    trade    small    right    understands    disciplinary    competitive    engineered    overcome    biology    minimize    automated    automation    cutiss    transplantation    forefront    visibility    engineering    mechatronics    introduction    barriers    continue    box    skin    tissue    market    radically    burns    malformations    scarring    company    employment    grant    limited    budget    customized    internationalization    unknown    platform    ag    producible    opportunity    gmp    trials    put    brand    researcher    manual    perceived    multidisciplinary    envisaged    enterprise    associate    possesses    autografts    sufficient    personalized    expert    companies    initial    standard    start    world    denovoskin    career    human    industrially    innovation    bio    skinfactory    cell    salary    clinical    demand    larger    delivered    relatively    recruitment    treatments    swiss    successful    compete    lines    defects    develops    translation    manufacturing   

Project "SkinFactory 2.0" data sheet

The following table provides information about the project.

Coordinator
CUTISS AG 

Organization address
address: WEINBERGSTRASSE 35 WYSS TRANSLATIONAL CENTER ZURICH DENOVOS
city: ZURICH
postcode: 8006
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Switzerland [CH]
 Total cost 183˙125 €
 EC max contribution 183˙125 € (100%)
 Programme 1. H2020-EU.2.3.2.2. (Enhancing the innovation capacity of SMEs)
 Code Call H2020-INNOSUP-2019-02
 Funding Scheme CSA
 Starting year 2019
 Duration (year-month-day) from 2019-11-25   to  2020-11-24

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    CUTISS AG CH (ZURICH) coordinator 183˙125.00

Map

Leaflet | Map data © OpenStreetMap contributors, CC-BY-SA, Imagery © Mapbox

 Project objective

CUTISS AG is a Swiss start-up company that develops customized human skin autografts (denovoSkin™) for the treatment of large skin defects like burns and malformations. DenovoSkin™ possesses the right features to minimize scarring after transplantation and is currently in clinical phase II in Europe. While manual production of denovoSkin™ is sufficient in the development phase and clinical trials, automation of the manufacturing process is essential to scale the technology for larger demand and internationalization, and to be competitive with current standard treatments. The proposed recruitment of an Innovation Associate will have significant impact on the development of an automated system for the manufacturing of denovoSkin™ (SkinFactory 2.0), enabling production lines at industrial scale and around the world. The grant will help to overcome the recruitment barriers of being a relatively unknown, small start-up enterprise that cannot compete with larger companies due to limited visibility, brand awareness, (perceived) career opportunities, salary and recruitment budget. The translation of the manual production process of denovoSkin™ to an GMP-in-a-box automation platform requires the employment of a multi-disciplinary researcher that understands both the cell biology and complex requirements of tissue engineering as well as the mechatronics and industrial design of automation. The envisaged Innovation Associate has to bring a multidisciplinary set of skills in to CUTISS and will have the opportunity to become an expert in the emerging field of bio-engineering. It is in the interest of the company to continue the employment after the initial year in order to develop the delivered prototype into an industrially producible end product. Successful market introduction of SkinFactory 2.0 will put CUTISS in the forefront of a new, emerging field of automated production of personalized, bio-engineered tissue, which is expected to change medicine radically.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SKINFACTORY 2.0" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SKINFACTORY 2.0" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.3.2.2.)

ImpAct Agencies (2019)

Impact Actions for social innovation agencies

Read More  

INNOVACTIS 2020-2021 (2020)

INNOVACTIS 2020-2021

Read More  

EENINNOAUSTRIA4 (2020)

Establishing Services Enhancing the Innovation Management Capacity of SMEs in the Enterprise Europe Network Austria

Read More